|
BioSeek, Merck Serono extend partnership
May 2012
SHARING OPTIONS:
SOUTH SAN FRACISCO—BioSeek LLC, a subsidiary of Asterand
PLC, recently signed a three-year collaboration agreement with Merck Serono, a
division of Merck KGaA, which extends and expands their previous three-year
agreement from 2009. Per the new agreement, BioSeek will expand the use of its
proprietary BioMAP platform to evaluate small-molecule compounds and proteins
from Merck Serono from a variety of therapeutic areas, aiming for target
differentiation, lead selection and optimization and nomination of candidates
for development.
“The studies carried out by BioSeek for Merck Serono over
the past three years have demonstrated that BioMAP Platform can be used to reliably
advance promising molecules through preclinical evaluation … we look forward to
our continuing and expanding research with them,” said Jack Davis, chairman and
interim CEO at Asterand. Back |
|
||
|
Home |
FAQs |
Search |
Submit News Release |
Site Map |
About Us |
Advertising |
Resources |
Contact Us |
Terms & Conditions |
Privacy Policy
|